Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 175 of 6351
-
Heart rate drug may speed recovery from shock after heart attack
Disease control Recruiting nowBrief Summary: The IVASHOCK trial investigates whether ivabradine can achieve at least one-class improvement in SCAI cardiogenic shock classification compared to placebo, and evaluates its safety profile in patients with cardiogenic shock (CS). Primary Objectives: 1. To determ…
Phase 3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
AI 'PANDAPro' hunts hidden pancreatic cancers in 100,000 CT scans
Diagnosis OngoingThe purpose of this study is to build upon the previously developed deep learning-based non-contrast CT pancreatic cancer screening model, PANDA. The model will first undergo training and enhancement, followed by external validation across multiple centers. Subsequently, a large-…
Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Can a drug combo and radiation shrink biliary tract tumors?
Disease control Recruiting nowThis is a prospective, single-arm, exploratory interventional study designed to evaluate the efficacy and safety of liposomal irinotecan (II) plus fluorouracil/leucovorin (5-FU/LV) and sintilimab with sequential stereotactic body radiation therapy (SBRT) as first-line treatment f…
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New Light-Based device could spot brain bleeds in minutes without a CT scan
Diagnosis Not yet recruitingTraumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complications of moderate-to-severe TBI is intracranial hemorrhage (ICH). If not identified and treated promptly, ICH can rapidly l…
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Spinal implant aims to restore walking in paralyzed patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of Epidural Electrical Stimulation (EES) combined with rehabilitation training for the reconstruction of walking in patients with chronic spinal cord injury (SCI) classified as AIS B-D. The main questions…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can fewer Pre-Surgery doses of immunotherapy beat more in head and neck cancer?
Disease control Recruiting nowThis study aims to explore the optimal course of neoadjuvant immunotherapy for HNSCC by comparing the efficacy and safety of 4 cycles and 2 cycles of neoadjuvant tislelizumab combined with chemotherapy.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for Crohn's: duvakitug enters final testing phase
Disease control Recruiting nowThis is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study durat…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Foam that stops bleeding from the inside: new trial underway
Disease control Recruiting nowThe purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.
Sponsor: Arsenal Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
Prevention Recruiting nowPeanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on matern…
Sponsor: University of Rochester • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Diaper photos may spot hidden liver disease in babies
Diagnosis Recruiting nowThis observational study evaluates whether a machine-learning algorithm, a computer program that learns patterns from data, can accurately diagnose cholestasis in newborns. Cholestasis refers to reduced or blocked bile flow from the liver, which can lead to liver damage. A severe…
Sponsor: Birmingham Women's and Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New shot could stop dangerous swelling attacks in HAE
Disease control OngoingThis is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent participants with type 1 or type 2 hereditary angioedema (HAE). The goal of this clin…
Phase 3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a biweekly shot rival weekly Weight-Loss drugs?
Disease control CompletedThis is a Phase 2 study to evaluate the safety and efficacy of 24, 36, and 48 mg GZR18 (Q2W) compared with placebo and 15 mg tirzepatide (QW). The study will evaluate weight management in participants with obesity (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with weight-…
Phase 2 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New blood test could spot liver cancer sooner
Diagnosis Recruiting nowHepatocellular carcinoma (HCC) is often diagnosed at an advanced stage, and early detection is critical for improving patient outcomes. Despite this, reliable non-invasive biomarkers for early-stage HCC are limited. This study seeks to develop a multi-omics-based liquid biopsy a…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can surgery after chemoradiation boost lung cancer control?
Disease control Recruiting nowLung cancer presents a significant treatment challenge, particularly in the heterogeneous stage III NSCLC patient population. While chemotherapy combined with high-dose radiotherapy (60 Gy in 30 fractions of 2 Gy once daily) is currently the recommended approach for unresectable …
Phase 4 • Sponsor: Idris Bahce • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A simple fix for myopia could change education for millions
Prevention OngoingChinese children are some of the most short-sighted in the world, but only one in five children in poor areas who needs glasses has them. Our team has already shown in other trials that giving children free glasses leads to better grades and that free glasses have a bigger impact…
Sponsor: Queen's University, Belfast • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Can a new heart pump outperform the standard during High-Risk angioplasty?
Disease control CompletedThis study is conducted to compare the effectiveness of a new percutaneous mechanical circulatory support device called SynFlow 3.0 with VA-ECMO in high-risk percutaneous coronary intervetnion(PCI) patients. The objective of this study is to see if SynFlow 3.0 can provide similar…
Sponsor: ForQaly Medical (Shanghai) Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug aims to halt liver scarring in 2,150 patients with fatty liver disease
Disease control Recruiting nowThis is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.
Phase 3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for lymphoma: drug combo aims to beat chemo
Disease control Recruiting nowThis is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab combination compared to Investigator's choice of 3 standard immunochemotherapy regimen, conducted in …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could less chemo be enough? new trial aims to treat High-Risk neuroblastoma with reduced therapy
Disease control Recruiting nowThe purpose of this study is to find out whether N10 chemotherapy is a safe and effective treatment for children with high-risk neuroblastoma.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Triple-Drug cocktail aims to boost remission in follicular lymphoma
Disease control Recruiting nowThis is a single center, open label, single arm phase II clinical trial. The objective of this study is to assess the feasibility and efficacy of zanubrutinib combined with venetoclax and Rituximab in patients with previously untreated follicular lymphoma (FL) .
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC